He Jiankui’s Genetic Misadventure, Part 3: What Are the Major Ethical Issues?
By Jing-Bao Nie and Alexander T.M. Cheung,
The Hastings Center
| 01. 10. 2019
In their single-minded venture of “producing” (shengchan, in their own word) the world’s first gene-edited babies, He Jiankui and his associates have posed numerous and daunting ethical challenges to China and the world. They can be mapped or identified through these four categories:
- typical problems related to research ethics;
- broader political, socio-cultural, and transcultural issues;
- fundamental ethical questions on the use of gene editing in human reproduction itself; and
- even more fundamental matters on the moral goals of science and technology.
Different levels of ethical issues should be explored in an interconnected and interdisciplinary approach, but it is important to note that ethical soundness on one dimension does not mean moral justification on any other level or dimension.
Some prominent U.S. scientists, including George Church at Harvard, have offered a defence of He’s human experimentation on two grounds. First, genetically editing humans can be ethically justifiable. Second, the international community and Chinese society are bullying He for having not done “the paperwork right.” Church says he feels “an obligation to be balanced” about He’s case. Some international and Chinese...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...